CapsoVision, Inc. Announces $100M ATM Share Offering Agreement

What Happened

• CapsoVision, Inc. announced on August 13, 2026 that it entered into a Controlled Equity OfferingSM Sales Agreement with Cantor Fitzgerald & Co. under which the company may, at its discretion and from time to time, offer and sell shares of its common stock having an aggregate offering price of up to $100,000,000.
• The company filed a Registration Statement on Form S-3 (File No. 333-298315) and an at-the-market prospectus supplement with the SEC on August 13, 2026. O’Melveny & Myers LLP issued a legal opinion dated August 13, 2026 regarding the validity of the shares to be sold; that opinion is filed as an exhibit to the 8-K.

Key Details

• Agreement counterparty: Cantor Fitzgerald & Co. acting as sales agent (or principal).
• Maximum offering amount: up to $100,000,000 of common stock.
• Agreement and related prospectus supplement and Form S-3 were filed with the SEC on August 13, 2026.
• Legal opinion from O’Melveny & Myers LLP dated August 13, 2026 is included as Exhibit 5.1.

Why It Matters

• This at-the-market (ATM) program gives CapsoVision a flexible mechanism to raise capital by selling common shares over time rather than in a single large offering.
• If the company sells shares under the program, existing shareholders would experience dilution; the timing, amount and price of any sales are at the company’s discretion and depend on market conditions.
• For investors, the filing signals that CapsoVision has an available capital-raising tool to fund operations or strategic needs, but there is no guarantee shares will be sold or how proceeds will be used unless the company discloses that in future filings.